← Back to Search

Practice Facilitation for Human Papillomavirus Vaccines

N/A
Waitlist Available
Led By Pamela C Hull, PhD
Research Sponsored by Pamela Hull
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up annually, up to 3 years post baseline
Awards & highlights

Study Summary

This trial is testing two ways to help community pediatric practices increase HPV vaccination rates. One is traditional in-person coaching, and the other is lower-resource web-based coaching. The goal is to find out which is more effective and sustainable.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~annually, up to 3 years post baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and annually, up to 3 years post baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Age-appropriate completion rate (ages 13-17)
Secondary outcome measures
Age at vaccination
Age-appropriate completion rate (at age 13)
Age-appropriate initiation rate (ages 13-17)
+6 more
Other outcome measures
Bundling adolescent vaccines rate
Documented recommendation rate (all visits)
Documented recommendation rate (well visits)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Web-Based CoachingExperimental Treatment1 Intervention
Web-based delivery of practice facilitation for HPV vaccine
Group II: In-Person CoachingExperimental Treatment1 Intervention
In-person delivery of practice facilitation for HPV vaccine
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Practice facilitation for HPV vaccine
2018
N/A
~420

Find a Location

Who is running the clinical trial?

Pamela HullLead Sponsor
National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,952,943 Total Patients Enrolled
Pamela C Hull, PhDPrincipal InvestigatorVanderbilt University Medical Center
1 Previous Clinical Trials
60 Total Patients Enrolled

Media Library

Practice facilitation for HPV vaccine Clinical Trial Eligibility Overview. Trial Name: NCT03399396 — N/A
Human Papillomavirus Vaccines Research Study Groups: Web-Based Coaching, In-Person Coaching
Human Papillomavirus Vaccines Clinical Trial 2023: Practice facilitation for HPV vaccine Highlights & Side Effects. Trial Name: NCT03399396 — N/A
Practice facilitation for HPV vaccine 2023 Treatment Timeline for Medical Study. Trial Name: NCT03399396 — N/A
~58 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top